Nikita Shah Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Nikita Shah is Executive Vice President of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 438,069 shares of AMRX, which is worth approximately $3.81 Million. The most recent transaction as insider was on Mar 04, 2025, when has been sold 18,353 shares (Class A Common Stock) at a price of $8.84 per share, resulting in proceeds of $162,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 438K

50.2% 3M change

11.85% 12M change

Total Value Held $3.81 Million

Nikita Shah Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2025	SELL Payment of exercise price or tax liability	$162,240 $8.84 p/Share	18,353 Reduced 4.02%	438,069 Class A Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	35,879 Added 7.29%	456,422 Class A Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$1,017,281 $8.76 p/Share	116,128 Reduced 21.64%	420,543 Class A Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	-	227,032 Added 31.46%	494,674 Class A Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$95,239 $8.67 p/Share	10,985 Reduced 3.43%	309,639 Class A Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	28,958 Added 8.28%	320,624 Class A Common Stock
Aug 14 2024	SELL Open market or private sale	$775,000 $7.75 p/Share	100,000 Reduced 25.53%	291,666 Class A Common Stock
Mar 03 2024	SELL Payment of exercise price or tax liability	$225,008 $5.47 p/Share	41,135 Reduced 9.5%	391,666 Class A Common Stock
Mar 03 2024	BUY Exercise of conversion of derivative security	-	82,103 Added 16.53%	414,648 Class A Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$83,040 $5.47 p/Share	15,181 Reduced 4.15%	350,698 Class A Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	28,957 Added 7.33%	365,879 Class A Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$106,605 $5.71 p/Share	18,670 Reduced 5.25%	336,922 Class A Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	-	35,620 Added 9.11%	355,592 Class A Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$34,682 $1.92 p/Share	18,064 Reduced 5.34%	319,972 Class A Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	36,232 Added 9.68%	338,036 Class A Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$46,103 $2.09 p/Share	22,059 Reduced 6.81%	301,804 Class A Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	40,687 Added 11.36%	317,359 Class A Common Stock
Feb 27 2023	SELL Payment of exercise price or tax liability	$42,664 $2.16 p/Share	19,752 Reduced 6.52%	283,176 Class A Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	35,620 Added 10.52%	302,928 Class A Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$7,575 $3.4 p/Share	2,228 Reduced 0.83%	267,308 Class A Common Stock
May 07 2022	BUY Exercise of conversion of derivative security	-	4,442 Added 1.62%	269,536 Class A Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$55,678 $4.45 p/Share	12,512 Reduced 4.51%	265,094 Class A Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	40,685 Added 12.93%	273,999 Class A Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$53,680 $4.59 p/Share	11,695 Reduced 4.7%	236,921 Class A Common Stock
Feb 27 2022	BUY Exercise of conversion of derivative security	-	35,620 Added 12.53%	248,616 Class A Common Stock

Nikita Shah

Executive Vice President

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account